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T Helper Type 2-Biased Natural Killer Cell Phenotype
in Patients with Pemphigus Vulgaris
Hayato Takahashi1, Masayuki Amagai1, Akiko Tanikawa1, Shigeaki Suzuki2, Yasuo Ikeda3, Takeji
Nishikawa1, Yutaka Kawakami4 and Masataka Kuwana3
Pemphigus vulgaris (PV) is an autoantibody-mediated bullous disease, but the role of natural killer (NK) cells in
its pathogenic process has never been examined in detail. Circulating CD56þCD3 NK cells as well as CD69þ -
activated NK cells were increased in PV patients compared with healthy controls and patients with other
autoantibody-mediated autoimmune diseases, including immune thrombocytopenic purpura and myasthenia
gravis. Gene expression analysis of highly purified NK cells demonstrated an increased expression of IL-10 and
decreased expression of IL-12Rb2, perforin, and granzyme B ex vivo in PV patients versus healthy controls. The
NK cells from PV patients also showed impaired signal transducer and activator of transduction4
phosphorylation upon in vitro IL-12 stimulation. Moreover, NK cells from PV patients exhibited reduced IL-10
production in response to in vitro stimulation with IL-2/IL-12. Finally, IL-5 expression in NK cells was exclusively
detected ex vivo in PV patients with active disease, and was lost in subsequent analyses performed during
disease remission. Together these findings suggest that NK cells contribute to a T helper type 2-biased immune
response in PV patients through impaired IL-12 signaling and an upregulation of IL-10 and IL-5.
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INTRODUCTION
Pemphigus vulgaris (PV) is an autoimmune bullous disease
mediated by anti-desmoglein 3 (Dsg3) autoantibodies that are
capable of directly causing acantholysis in the epidermis
(Amagai et al., 1991, 1992; Tsunoda et al., 2003; Payne et al.,
2005). The production of anti-Dsg3 autoantibodies in PV
patients was shown to result from a functional collaboration
between Dsg3-specific B and T cells (Nishifuji et al., 2000;
Veldman et al., 2004b), but recent accumulating evidence
indicates that regulatory mechanisms play an important role
in controlling the pathogenic autoimmune response (Kronen-
berg and Rudensky, 2005). Potential cell types that modulate
the autoimmune response include regulatory T cells, natural
killer (NK) cells, and natural killer T cells. In this regard,
Dsg3-specific T regulatory type 1 cells have the capacity to
inhibit Dsg3-specific T helper type 2 (Th2) cells in vitro
(Veldman et al., 2004a). On the other hand, the roles of NK
and natural killer T cells in the pathogenesis of PV have not
been evaluated to date. NK cells have long been regarded as
an essential component of innate immunity, because they
exert nonspecific cytotoxic activity against virus-infected
cells and tumor cells (Robertson and Ritz, 1990). However,
recent studies have revealed that NK cells are also the source
of various cytokines, including both Th1 and Th2 cytokines
(Warren et al., 1995; Mehrotra et al., 1998; Hoshino et al.,
1999), and they control the adaptive immune response by
interacting directly with dendritic cells, T cells, and B cells
(Blanca et al., 2001; Mailliard et al., 2003; Zingoni et al.,
2004). Natural killer T cells are also capable of producing
large amounts of both Th1 and Th2 cytokines upon
stimulation and thereby controlling the acquired immune
response (Van Kaer, 2005).
In this study, we investigated the involvement of these cell
types and their potential regulatory functions in the auto-
immune pathogenesis of PV, and found a unique Th2-biased
property of NK cells.
RESULTS
Increased and activated circulating NK cells in PV patients
Flow cytometric analysis was performed to examine the
proportions of lymphocyte subsets, including those with
potential regulatory functions, such as naturally occurring
CD4þCD25high regulatory T cells, CD56þCD3þ natural
killer T cells, and CD56þCD3 NK cells from 22 PV patients,
including two with active disease, and from 28 healthy
controls (Table 1). A statistically significant difference was
detected only for the proportion of NK cells (P¼0.003).
A representative flow cytometric finding for NK cells is shown
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in Figure 1a. Additional analyses of samples from 11 immune
thrombocytopenic purpura (ITP) patients and 10 myasthenia
gravis (MG) patients revealed that the increase in NK cells
was unique to PV (Figure 1b). The absolute number of
circulating NK cells was also significantly increased in PV
patients compared with healthy controls (P¼0.03, Figure 1c).
We repeatedly assessed the NK cell proportion at different
time points (interval 34–161 days) in four PV patients and
three healthy controls, and found that the standard deviation
of two sequential measurements was o4.0%.
We next evaluated the activation status of NK cells by
examining the expression of CD69, a cell-surface marker
expressed on activated NK cells (Marzio et al., 1999). The
proportion of CD69þ -activated NK cells in PV patients was
significantly increased compared with the proportion in ITP
patients, MG patients, or healthy controls (Figure 1d). These
findings together indicate that NK cells were activated and
expanded in the peripheral blood of PV patients.
Lack of difference in NK activity between PV patients and
healthy controls
We assessed the NK activity in the peripheral blood mono-
nuclear cell fraction from 14 PV patients and 12 healthy
controls. NK cells from all the subjects showed cytotoxicity in
an effector-to-target ratio-dependent manner. There was no
statistically significant difference in the NK activity between
PV patients and healthy controls (21.6714.3% vs
17.0710.5%), even though the proportion and activation
status of the NK cells were higher in PV patients compared
with healthy controls.
Upregulated expression of the IL-10 gene and downregulated
expression of the IL-12Rb2, perforin, and granzyme B genes in
NK cells from PV patients
To identify genes whose expression levels in NK cells were
different between PV patients and healthy controls, we first
carried out semi-quantitative PCR to evaluate the mRNA
expression levels of 14 genes potentially involved in the
regulatory function of NK cells, in NK cell preparations from
four PV patients in remission, and four healthy controls (Table
S1). A significant difference in the gene expression level
between these two groups was detected for IL-10, which was
upregulated in PV patients and for the IL-12 receptor b2
(IL-12Rb2), perforin, and granzyme B, which were down-
regulated in PV patients, compared with healthy controls.
To confirm these findings, we used the TaqMans PCR
system to quantify the mRNA expression levels in a larger
number of subjects: six PV patients with active disease, 13 PV
patients in remission, and 11 healthy controls (Figure 2). The
expression of IL-10 was again significantly higher, and the
expression of IL-12Rb2, perforin, and granzyme B was
significantly lower in PV patients in remission and with
active disease, compared with healthy controls. There was no
difference in the expression levels of these four genes
between PV patients with active disease and those in
remission.
Impaired IL-12 signaling in NK cells from PV patients
The decreased IL-12Rb2 gene expression in the NK cells
from PV patients could potentially lead to impaired IL-12
signaling. To test this hypothesis, NK cells from five PV
patients, including one with active disease, and five healthy
controls were stimulated with IL-12 and examined for the
Table 1. Proportion of lymphocyte subsets in
peripheral blood from PV patients and healthy
controls determined by flow cytometric analysis1
PV (n=22) Healthy controls (n=28) P-value
CD4+ 37.6714.5 37.5711.9 NS
CD8+ 30.4711.2 27.0711.0 NS
CD19+ 7.574.7 9.274.0 NS
CD4+CD25high 2 2.171.1 1.770.8 NS
CD56+CD3+ 6.177.8 3.473.5 NS
CD56+CD3 21.3713.4 10.877.0 0.003
PV, pemphigus vulgaris; NS, not significant.
1Results are shown as the mean7SD (%). Comparisons were made by the
Mann–Whitney U-test.
2Sample numbers of PV patients and healthy controls were 18 and 27,
respectively.
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Figure 1. Analysis of NK cells in the peripheral blood from PV patients,
ITP patients, MG patients, and healthy controls, by flow cytometry.
(a) Representative density plot analysis for evaluating the expression of CD56
and CD3 in a PV patient and healthy control. The cells in the lymphocyte
fraction, gated on forward and side scatter, were evaluated. The numbers
indicate the proportions of cells in the corresponding quadrants in the lower
part. The upper left portion (CD56þCD3) corresponds to NK cells. (b) The
proportion of CD56þCD3 NK cells in the circulating lymphocytes of 22 PV
patients (two with active disease), 11 ITP patients, 10 MG patients, and 28
healthy controls. (c) The absolute number of CD56þCD3 NK cells in 1 ml of
peripheral blood from 12 PV patients (one with active disease) and 13 healthy
controls. (d) The proportion of CD69þ -activated NK cells in the total NK cells
of 15 PV patients (one with active disease), 11 ITP patients, 10 MG patients,
and 18 healthy controls. Comparisons were made by the Mann–Whitney
U-test. Horizontal bars represent the mean values.
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phosphorylation of signal transducer and activator of
transduction (Stat)4, one of the downstream events selectively
induced by IL-12 signaling (Jacobson et al., 1995). Immuno-
blotting of the cellular lysates of IL-12-stimulated NK cells to
detect phosphorylated and total Stat4 revealed that the
degree of Stat4 phosphorylation was significantly lower in
PV patients than in healthy controls (P¼0.008; Figure 3).
Reduced IL-10 production from NK cells upon in vitro
stimulation with IL-2 and IL-12 in PV patients
To confirm the upregulated IL-10 expression in NK cells from
PV patients at a protein level, we measured IL-10 concentra-
tion in NK cell lysates using ELISA. However, IL-10
concentration was below the detection limit despite utiliza-
tion of a highly sensitive commercial kit. NK cells were then
stimulated with or without a combination of IL-2 and IL-12, a
well-known stimulant for IL-10 production from NK cells
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Figure 2. Relative mRNA expression levels of IL-10, IL-12Rb2, perforin, and
granzyme B in the NK cells from PV patients with active disease (aPV), PV
patients in remission (rPV), and healthy controls. Total RNA was prepared
from sorted CD56þCD3 cells and subjected to Taqmans quantitative PCR.
Individual mRNA expression levels were normalized to the mRNA expression
level of GAPDH. Comparison was made by the Mann–Whitney U-test.
Horizontal bars represent the mean values.
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Figure 3. The degree of Stat4 phosphorylation in IL-12-stimulated NK cells
in PV patients and healthy controls. (a) Sorted NK cells from five PV patients
(one with active disease) and five healthy controls were stimulated with IL-12
in vitro, and subjected to immunoblot analysis to detect phosphorylated Stat4
(pStat4) and total Stat4. (b) The degree of Stat4 phosphorylation in five PV
patients and five healthy controls. Comparison was made by the
Mann–Whitney U-test. Horizontal bars represent the mean values.
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Figure 4. IL-10 production by NK cells from PV patients and healthy
controls, upon in vitro stimulation with a combination of IL-2 and IL-12.
NK cells freshly isolated from seven PV patients and nine healthy controls
were cultured with IL-2 and IL-12 for 3 days, and the culture supernatants
were subjected to ELISA for measurement of IL-10. Comparison was made by
the Mann–Whitney U-test. Horizontal bars represent the mean values.
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Figure 5. IL-5 expression in NK cells from PV patients according to the
disease activity. (a) IL-5 and GAPDH expression by RT-PCR in sorted NK cells
from four PV patients in remission, a PV patient with active disease, and four
healthy controls. (b) IL-5 mRNA expression levels determined using Taqmans
quantitative PCR in six PV patients with active disease (aPV), 13 PV patients in
remission (rPV), and 11 healthy controls. Each mRNA expression level was
normalized to the GAPDH mRNA expression level. A relative mRNA
expression level lower than 0 means the value was below the detectable limit.
Comparison was made by the Mann–Whitney U-test. Horizontal bars
represent the mean values.
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(Mehrotra et al., 1998). IL-10 was undetectable without the
stimulation. Interestingly, upon in vitro IL-2/IL-12 stimulation,
NK cells from PV patients produced significantly less IL-10
than did those from healthy controls (P¼0.01; Figure 4).
Upregulated IL-5 gene expression in NK cells from PV patients
with active disease
In patients with multiple sclerosis, IL-5 expression by NK cells
is upregulated in remission, but not in the active disease
phase (Takahashi et al., 2001). In contrast, we failed to detect
IL-5 mRNA in the PV patients in remission (Table S1). When
the NK cells from additional PV patients were examined, IL-5
mRNA expression was detected exclusively in the patient
with active disease (Figure 5a). The IL-5 expression by NK
cells was further evaluated in 19 PV patients, including six
with active disease, and 11 healthy controls using TaqMans
quantitative PCR (Figure 5b). IL-5 mRNA expression was
detected in four PV patients with active disease (67%), but in
none of 13 PV patients in remission. Serial analysis in two PV
patients with active disease revealed the loss of IL-5
expression after the disease became quiescent.
DISCUSSION
We demonstrate here that NK cells are quantitatively and
phenotypically altered in PV patients as follows: (i) an
increased proportion and absolute number of NK cells in
circulation; (ii) an increased proportion of CD69þ -activated
cells; (iii) downregulated IL-12Rb2, perforin, and granzyme B
genes; (iv) impaired IL-12-induced Stat4 phosphorylation;
(v) upregulated expression of IL-10; (vi) reduced IL-10 produc-
tion upon in vitro IL-2/IL-12 stimulation; and (vii) upregulated
expression of IL-5 in association with active disease status.
The NK cells have been quantitatively analyzed in several
autoimmune and inflammatory diseases. The majority of
these diseases, including multiple sclerosis, Graves’ disease,
and psoriasis, are associated with a decreased proportion of
NK cells (Kastrukoff et al., 1998; Rojano et al., 1998;
Cameron et al., 2003), but PV patients showed an increased
proportion. In addition, the in vivo activation of NK cells
appears to be unique to PV patients, because ITP patients and
MG patients lacked this feature. Several lines of evidence
indicate that NK cells control the fate of the autoimmune
response. Specifically, the depletion of NK cells increases the
severity of experimental autoimmune encephalomyelitis, a
mouse model for multiple sclerosis, which is a well-
documented Th1-mediated autoimmune disease (Zhang
et al., 1997). In contrast, NK-cell depletion delays the onset
of disease and diminishes the severity of experimental
autoimmune MG, a model for autoantibody-mediated auto-
immune disease (Shi et al., 2000). These findings indicate that
regulatory roles of NK cells in the pathogenic immune
response are different among the autoimmune diseases.
NK cells reside not only in the peripheral blood, but also
in the spleen and lymph nodes (Ferlazzo et al., 2004), where
the interaction between autoreactive T and B cells primarily
occurs (Kuwana et al., 2002; Kent et al., 2005). The
recruitment of NK cells into the lymph nodes results in
induction of the Th1 response by secretion of IFN-g (Martin-
Fontecha et al., 2004). In PV patients, circulating NK cells
showed characteristic gene expression profiles, irrespective
of the disease status, that is, downregulated IL-12Rb2 and
upregulated IL-10. Because IL-12Rb2 is a key molecule in
Th1 differentiation (Chan et al., 1991; Yoshida et al., 1994;
Ma et al., 1996), the downregulated IL-12Rb2 mRNA
expression and impaired IL-12 signaling in NK cells observed
in PV patients may lead to a reduced capacity to induce the
Th1 response. Taken together with the upregulated expres-
sion of IL-10 mRNA, it is likely that NK cells contribute to a
Th2-biased environment in PV patients. As one of the effects
of IL-10 on B cells is to promote production of antibodies,
especially of the IgG4 isotype (Jeannin et al., 1998), the
upregulated IL-10 expression in NK cells may result in the
IgG4-dominant anti-Dsg3 autoantibody response observed in
PV patients irrespective of the disease status (Jones et al.,
1988; Shirakata et al., 1990; Wilson et al., 1993; Futei et al.,
2001).
In contrast to upregulated IL-10 mRNA expression ex vivo,
NK cells from PV patients produced less IL-10 than did those
from healthy controls upon in vitro IL-2/IL-12 stimulation.
This phenomenon might be explained by impaired IL-12
signaling observed in NK cells from PV patients. In this case,
in vivo IL-10 upregulation by NK cells in PV patients is
potentially mediated through IL-12-independent pathway.
Alternatively, NK cells are already activated and exhausted in
vivo in PV patients.
We also found an upregulated expression of IL-5, another
Th2 cytokine, exclusively in PV patients with active disease.
Interestingly, this pattern of IL-5 expression in NK cells in
association with the disease status is completely opposite to
that seen in multiple sclerosis patients, in whom IL-5 is
upregulated in remission, but downregulated in the active
phase (Takahashi et al., 2001). Distinct gene expression
controls by the NK cells in PV and multiple sclerosis might
reflect a difference in the role of Th1/Th2 balance in the
disease pathogenesis. As IL-5-producing NK cells inhibit the
Th1 response and drive Th2 polarization (Takahashi et al.,
2001), the expression of IL-5 by NK cells in patients with
active PV further enhances the Th2-biased environment. This
might also explain why IgE anti-Dsg3 antibodies are detected
in PV patients with active disease, but not in those in
remission (Spaeth et al., 2001), because IL-5 is known to
enhance IgE secretion (Pene et al., 1988; Vercelli et al.,
1989).
In summary, our findings suggest that NK cells may be
involved in the pathogenic autoimmune response in PV
patients by promoting Th2 polarization, although additional
studies using serial samples collected before and after the
initiation of the treatment are necessary to confirm our theory.
MATERIALS AND METHODS
Patients and controls
We studied 28 patients (12 men) with PV that were diagnosed on the
basis of all the following findings: (1) suprabasal acantholysis by
histological examination; (2) IgG deposition on the keratinocyte cell
surfaces by direct immunofluorescence; and (3) a positive test for
serum IgG anti-Dsg3 antibody. The average age at examination was
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51.0710.8 years. Nine patients (32%) had additional IgG anti-Dsg1
antibody. At the time of blood sample collection, six patients had
active disease, and the remaining 22 were in clinical remission,
defined as having had no bullae or erosions during the past
2 months, irrespective of treatment.
We also examined 11 patients (two men) with ITP and 10 (two
men) with MG to control for autoantibody-mediated autoimmune
disease. The average age at examination of the ITP patients and MG
patients was 53.7719.2 and 53.5718.4 years, respectively. The
diagnoses of ITP and MG were based on the published criteria
(Drachman, 1994; George et al., 1996). Thirty-five healthy
individuals (13 men) were also used as control subjects, and their
average age at examination was 47.5720.1 years. There was no
statistically significant difference in sex distribution or age at
examination between the PV patient group and the individual
control groups. Twenty-two PV patients (76%), four ITP patients
(36%), and six MG patients (60%) were taking low-dose predniso-
lone at the time of blood collection, and the mean daily dosage was
9.3 mg (range 1–19 mg), 8.1 mg (5–10 mg), and 5.8 mg (3–10 mg),
respectively. This study was approved by the Keio University
Institutional Review Board and conducted according to the
Declaration of Helsinki Principles. Written informed consent was
obtained from all the subjects.
Flow cytometric analysis
Peripheral blood mononuclear cells were incubated with fluor-
escence-conjugated mouse monoclonal antibodies, including
anti-CD3-FITC, anti-CD4-FITC, anti-CD8-phycoerythrin, anti-CD56-
phycoerythrin, anti-CD69-phycoerythrin-cyanin 5.1 (Beckman-Coul-
ter, Hialeah, FL), and anti-CD19-Cy-Chrome (Becton Dickinson, San
Diego, CA), followed by analysis with a FACSCaliburs flow
cytometer (Becton Dickinson). All analyses were performed on the
lymphocyte fraction gated based on the forward and side scatters.
The absolute number of the cells of interest was quantified as the
number per 1 ml of peripheral blood, based on the ratio to the
number of FlowCounts microbeads (Beckman-Coulter). Appropriate
fluorescence-labeled isotype-matched control antibodies were in-
cluded in all the analyses.
NK activity
The nonspecific cytotoxic activity of NK cells was measured by the
51Cr release assay according to a previously described method
(Lanier et al., 1983) with some modifications. Briefly, 51Cr-labeled
target cells (leukemia cell line K562) were mixed with freshly
isolated peripheral blood mononuclear cells at effector-to-target
ratios of 1:1, 5:1, 10:1, and 20:1 for 4 hours, and the radioactivity
released into the culture supernatants was measured using an
automatic gamma counter (Perkin-Elmer Life Sciences, Boston, MA).
Each assay was performed in triplicate, and the percent lysis was
calculated using the following formula: (experimental release
spontaneous release)/(maximal release in the presence of 1%
Triton Xspontaneous release) 100. NK activity was defined as the
percent lysis at an effector-to-target ratio of 20:1.
Isolation of NK cells
NK cells were highly purified by a two-step sorting process using a
MACS cell isolation system (Miltenyi Biotech, Bergisch Galdbach,
Germany). Namely, CD3þ and CD14þ cells were depleted from
peripheral blood mononuclear cells, then CD56þ cells were
positively selected. The proportion of CD56þCD3 NK cells in
the enriched fraction was 98.170.3%, as determined by flow
cytometric analysis.
Analysis of mRNA expression
Sorted NK cells were used to determine semi-quantitatively their
mRNA expression levels of 14 genes (listed in Table S2) that are
potentially associated with NK cell function. In brief, total RNA was
isolated using an RNeasy mini kit (Qiagen, Hilden, Germany), and
treated with AMV RTase XL (TAKARA BIO, Otsu, Japan) in the
presence of an oligo-dT primer to generate first-strand cDNA. The
cDNA equivalent to 5 ng total RNA was subjected to PCR under
the conditions shown in Table S2. The number of PCR cycles was
adjusted to assure that the correlation between the amplified product
and the amount of input cDNA fell within a linear range. The PCR
products were then fractionated on agarose gels and visualized by
ethidium bromide staining. The intensity of individual bands that
corresponded to the expected molecular size was semi-quantified
using NIH Images available at http://rsb.info.nih.gov/nih-image/.
The relative mRNA expression level was normalized to the
expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The mRNA expression of the selected genes was further analyzed
quantitatively using a Taqmans real-time PCR system with an ABI
PRISMs 7900HT (Applied Biosystems, Foster City, CA). cDNA
equivalent to 10 ng total RNA was subjected in duplicate to the
reactions according to the manufacturer’s protocol. Primer pairs and
a TaqMan probe for perforin, granzyme B, IL-5, and GAPDH were
purchased from Applied Biosystems, whereas those for IL-10 and
IL-12Rb2 were designed using Primer Expresss Software v2.0 (Applied
Biosystems) as follows: IL-10, sense (50-GGCGCTGTCATCGA
TTTCTT-30), antisense (50-CTTGGAGCTTATTAAAGGCATTCTTC-30),
probe (50-CAAGAGCAAGGCCGTGGAGCAGG-30); and IL-12Rb2,
sense (50-GGGCATTTTCTCAACGCATT-30), antisense (50-GCTGGA
TCTGGAATTTCTCTGCTA-30), probe (50-TTCTCCTAGCAGCCCTC
AGACCTCAGTG-30). The gene expression was standardized on the
basis of serial dilutions of cDNA prepared from a healthy
individual’s peripheral blood mononuclear cells that were stimu-
lated with phorbol 12-myrisate 13-acetate (25 ng/ml) and ionomycin
(1mg/ml) (Sigma, St Louis, MO). Relative expression levels were
normalized to the expression level of GAPDH.
Evaluation of phosphorylated Stat4 in NK cells
The phosphorylation status of Stat4 in NK cells was evaluated as
described previously (Toyoda et al., 2004). Briefly, sorted NK cells
were incubated with rIL-12 (50 ng/ml; R&D systems, Minneapolis,
MN) at 371C for 30 minutes. The soluble fraction derived from
105 cells was fractionated by SDS-7.5% polyacrylamide gel electro-
phoresis, and subjected to immunoblotting using the Can Get Signal
system (TOYOBO, Osaka, Japan) with rabbit anti-phosphorylated
Stat4 polyclonal antibodies (Zymed Laboratories, South San Fran-
cisco, CA) and peroxidase-conjugated anti-rabbit IgG antibodies
(Cappel, Aurora, OH). The antibodies that bound to the membrane
were subsequently visualized using Western LightningTM Chemilu-
minescence Reagent Plus (Perkin-Elmer Life Sciences, Boston, MA).
After a stripping treatment with RestoreTM Western Blot Stripping
Buffer (Pierce, Rockford, IL), the membrane was re-subjected to
immunoblotting using rabbit anti-Stat4 polyclonal antibodies (Santa
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Cruz Biotechnology, Santa Cruz, CA). The intensity of individual
bands was semi-quantitatively assessed using NIH Images. The
degree of phosphorylation was evaluated as the ratio of the intensity
of phosphorylated Stat4 to that of total Stat4.
Quantification of IL-10 production by NK cells
To quantify IL-10 in freshly isolated NK cells, soluble fractions
derived from NK cells (106 cells) were subjected to highly sensitive
ELISA (Quantikines HS; R&D systems) (sensitivity 0.5 pg/ml). To
evaluate IL-10 produced by NK cells upon in vitro stimulation, NK
cells (105/well) were cultured in 96-well flat-bottomed plates with or
without a combination of rIL-12 (10 ng/ml) and rIL-2 (100 U/ml;
Shionogi, Osaka, Japan) for 3 days. Culture supernatants were
harvested and IL-10 concentrations were measured by BD OptEIA
Human IL-10 ELISA (BD, Franklin Lakes, NJ) (sensitivity 2.0 pg/ml).
Statistical analysis
All comparisons for statistical differences between two patient
groups were performed using the Fisher’s two-tailed exact test or
Mann–Whitney U-test as appropriate.
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